The Recall Desk
Agency classClass IIOur severity:SevereFDA (Drugs)·D-0170-2027·Announced 2026-11-11

Fresenius Recalls DELFLEX Peritoneal Dialysis Solution Due to Sterility Concerns

Fresenius Medical Care is recalling specific lots of DELFLEX Peritoneal Dialysis Solution because small perforations in the bag print area may compromise sterility.

The agency’s classification

FDA (Drugs): Class II

Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 4/5 (Severe).

The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The recall is classified as FDA Class II due to a lack of assurance of sterility caused by potential leaks from perforations in the primary bag. The source does not report any illnesses, injuries, or deaths.

Plain-English summary

Fresenius Medical Care Renal Therapies Group, LLC is recalling 2,709 cases (5 bags per case) of DELFLEX Peritoneal Dialysis Solution with 2.5% Dextrose, Low Magnesium/Low Calcium. The affected product is a 2,500 mL single-dose bag, sterile and non-pyrogenic, with an attached stay"safe Exchange Set. The recall covers lots 25JGPD069, 25SGPD046, 25SGPD059, 25SGPD063, and 26EGPD022, which were distributed nationwide in the USA.

The recall was initiated due to a lack of assurance of sterility. Complaints were received regarding potential leaks from small perforations in the print area on the primary bag in the affected lots. This defect could potentially allow contamination of the dialysis solution.

Patients and healthcare providers should stop using the affected lots immediately. Consumers should check their inventory for the specific lot numbers and expiration dates listed above. If the product is found, it should be returned to the supplier or disposed of according to local regulations. Fresenius Medical Care is the recalling firm.

The recalled product

Product
DELFLEX (DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE)
Brand
DELFLEX

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (8)

  • Lot#: 25JGPD069
  • Exp 1/31/2027
  • 25SGPD046
  • 25SGPD059
  • 25SGPD063
  • Exp 6/30/2027
  • 26EGPD022
  • Exp 11/30/2027.

Distribution

Distributed nationwide across the United States.

Same manufacturer · Fresenius Medical Care Renal Therapies Group, LLC

See all →

Similar recalls